Cancer Clinical Trials in Houston, Texas

34 studies are recruiting for cancer in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies, page 2

1. Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

   To develop and measure the effects of a culturally sensitive yoga program for inpatients

   Stage

   Not phased

   Ages

   18 and older

   Site

   M D Anderson Cancer Center, Houston, Texas

   Locations

   3 in total

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT05681026 on ClinicalTrials.gov

2. Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

   This phase III clinical trial will evaluate the impact on survival of adding chaplain-provided spiritual care or psychotherapy/meditation to standard-of-care (SOC) and palliative measures, plus chemotherapy if recommended, and comparing it with SOC and palliative measures, plus chemotherapy if reco…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Houston Methodist Neal Cancer Center, Houston, Texas

   Run by

   The Methodist Hospital Research Institute

   See if you can join NCT07290491 on ClinicalTrials.gov

3. Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

   Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

   Stage

   Phase 2

   Ages

   2 to 99

   Site

   MD Anderson Cancer Center, Houston, Texas

   Locations

   5 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05783323 on ClinicalTrials.gov

4. Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

   To learn if Cognitive Behavior Therapy (called CBT), combined with either Bright Light Therapy (called BLT), methylphenidate, and/or melatonin, can help improve sleep and other related symptoms such as fatigue, anxiety, and depression in cancer patients. This is an investigational study. In this st…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   MD Anderson Cancer Center, Houston, Texas

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT05474846 on ClinicalTrials.gov

5. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

   International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

   Stage

   Not phased

   Ages

   Any age

   Site

   Massive Bio SYNERGY-AI site, Houston, Texas

   Locations

   68 in total

   Run by

   Massive Bio, Inc.

   See if you can join NCT03452774 on ClinicalTrials.gov

6. A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

   This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients …

   Stage

   Not phased

   Ages

   18 to 120

   Site

   Oncology Consultants, P.A., Houston, Texas

   Locations

   7 in total

   Run by

   N-Power Medicine

   See if you can join NCT06877884 on ClinicalTrials.gov

7. A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

   KB707-01 is a Phase 1/2, open-label, multicenter, dose escalation and expansion study. The study will evaluate the safety and tolerability of KB707 in adults with locally advanced or metastatic solid tumors who have progressed on standard of care therapy, cannot tolerate standard of care therapy, r…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   MD Anderson Cancer Center, Houston, Texas

   Locations

   15 in total

   Run by

   Krystal Biotech, Inc.

   See if you can join NCT05970497 on ClinicalTrials.gov

8. Trial of DFP-14927 in Advanced Solid Tumors

   This is a Phase I, open-label, single-arm, dose escalation study of DFP-14927 intravenous infusion administered to patients with refractory or relapsed solid tumors.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   MD Anderson Cancer Center, Houston, Texas

   Locations

   2 in total

   Run by

   Delta-Fly Pharma, Inc.

   See if you can join NCT03943004 on ClinicalTrials.gov

9. A Study in Patients With Advanced Cancers

   A first-in-human study using BIO-106 as a single agent and in combination with pembrolizumab in advanced cancers.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   University of Texas MD Anderson Cancer Center, Houston, Texas

   Locations

   3 in total

   Run by

   BiOneCure Therapeutics Inc.

   See if you can join NCT05320588 on ClinicalTrials.gov